PMGC Holdings (ELAB) EBITDA Margin (QoQ) (2022 - 2026)
PMGC Holdings (ELAB) EBITDA Margin (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.93 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.59 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 58.86 Bn | 53.73 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.42 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.19 Bn | 9.80 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - |
| 10 | PMGC Holdings | 30.82 Mn | 12.03 Mn | 385,691.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32,268.00 |
| Dec 31, 2025 | -4,243.00 |
| Mar 31, 2025 | -21,813.00 |
| Dec 31, 2024 | 47,248.00 |
| Sep 30, 2024 | 5,824.00 |
| Jun 30, 2024 | 4,130.00 |
| Mar 31, 2024 | 99,930.00 |
| Dec 31, 2023 | -157,133.00 |
| Sep 30, 2023 | 63,088.00 |
| Jun 30, 2023 | 25,985.00 |
| Mar 31, 2023 | -41,519.00 |
| Dec 31, 2022 | -6,862.00 |